Heron Therapeutics Overview
- Year Founded
-
1983
- Status
-
Public
- Employees
-
128
- Stock Symbol
-
HRTX
- Share Price
-
$0.31
- (As of Friday Closing)
Heron Therapeutics General Information
Description
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Contact Information
Website
www.herontx.comCorporate Office
- 25 Fenton Main Street
- Suite 300
- Cary, NC 27511
- United States
Corporate Office
- 25 Fenton Main Street
- Suite 300
- Cary, NC 27511
- United States
Heron Therapeutics Timeline
Heron Therapeutics Stock Performance
As of 13-Nov-2026, Heron Therapeutics’s stock price is $0.31. Its current market cap is $59.1M with 190M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.31 | $0.33 | $0.26 - $1.57 | $59.1M | 190M | 4.51M | -$0.12 |
Heron Therapeutics Financials Summary
As of 30-Sep-2026, Heron Therapeutics has a trailing 12-month revenue of $148M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 166,259 | 331,189 | 340,061 | 357,709 |
| Revenue | 148,215 | 154,904 | 144,285 | 127,044 |
| EBITDA | (19,651) | (10,238) | (8,598) | (107,155) |
| Net Income | (21,560) | (20,195) | (13,580) | (110,559) |
| Total Assets | 230,448 | 255,877 | 233,147 | 222,506 |
| Total Debt | 131,729 | 140,638 | 177,763 | 179,628 |
Heron Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Heron Therapeutics Comparisons
Industry
Financing
Details
Heron Therapeutics Competitors (36)
One of Heron Therapeutics’s 36 competitors is Axsome Therapeutics, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Axsome Therapeutics | Formerly VC-backed | New York, NY | ||||
| Protagonist Therapeutics | Formerly VC-backed | Newark, CA | ||||
| Citius Pharma | Formerly Angel backed | Cranford, NJ | ||||
| Idorsia Pharmaceuticals | Corporation | Allschwil, Switzerland | ||||
| Sarepta Therapeutics | Formerly VC-backed | Cambridge, MA |
Heron Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Heron Therapeutics Patents
Heron Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| DE-2144317-A1 | Toy balancing on a rope | Inactive | 31-Aug-1971 |
Heron Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Heron Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Heron Therapeutics ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
33.71 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Biotechnology
Subindustry
of 431
Rank
Percentile
Heron Therapeutics FAQs
-
When was Heron Therapeutics founded?
Heron Therapeutics was founded in 1983.
-
Where is Heron Therapeutics headquartered?
Heron Therapeutics is headquartered in Cary, NC.
-
What is the size of Heron Therapeutics?
Heron Therapeutics has 128 total employees.
-
What industry is Heron Therapeutics in?
Heron Therapeutics’s primary industry is Drug Discovery.
-
Is Heron Therapeutics a private or public company?
Heron Therapeutics is a Public company.
-
What is Heron Therapeutics’s stock symbol?
The ticker symbol for Heron Therapeutics is HRTX.
-
What is the current stock price of Heron Therapeutics?
As of 13-Nov-2026 the stock price of Heron Therapeutics is $0.31.
-
What is the current market cap of Heron Therapeutics?
The current market capitalization of Heron Therapeutics is $59.1M.
-
What is Heron Therapeutics’s current revenue?
The trailing twelve month revenue for Heron Therapeutics is $148M.
-
Who are Heron Therapeutics’s competitors?
Axsome Therapeutics, Protagonist Therapeutics, Citius Pharma, Idorsia Pharmaceuticals, and Sarepta Therapeutics are some of the 36 competitors of Heron Therapeutics.
-
What is Heron Therapeutics’s annual earnings per share (EPS)?
Heron Therapeutics’s EPS for 12 months was -$0.12.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
